Costello A H, Cisar J O, Kolenbrander P E, Gabriel O
Infect Immun. 1979 Nov;26(2):563-72. doi: 10.1128/iai.26.2.563-572.1979.
Human A, B, and O erythrocytes (RBC) were agglutinated by many human strains of Actinomyces viscosus and A. naeslundii. At 37 degrees C, these bacterium-mediated hemagglutination reactions required the action of bacterial neuraminidase upon the RBC; however, at 4 degrees C, the requirement for neuraminidase was not as striking. Bacterial cell suspensions which caused hemagglutination at 37 degrees C contained both soluble extracellular and cell-associated neuraminidase activities as shown by enzyme assays using a soluble substrate (i.e., alpha 1-acid glycoprotein). Bacterium-mediated hemagglutination occurred only in the presence of soluble neuraminidase activity, and the rate of hemagglutination could be inhibited by 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, a competitive inhibitor of purified soluble neuraminidase from A. viscosus T14V. Suspensions of bacteria which contained only cell-associated neuraminidase activity were unable to initiate hemagglutination, but they caused immediate hemagglutination when mixed with neuraminidase-treated RBC. All hemagglutination reactions were reversible in the presence of 0.02 M lactose and were abolished by heating (85 degrees C for 30 min) the actinomycete cells but not the RBC. The proposed mechanism of hemagglutination involves two sequential steps: (i) the action of neuraminidase to unmask galactose-containing receptors on the RBC and (ii) the multivalent binding of these receptors by many low-affinity lection sites on the bacterial surface.
人A、B和O型红细胞(RBC)可被许多人源黏性放线菌和内氏放线菌菌株凝集。在37℃时,这些细菌介导的血凝反应需要细菌神经氨酸酶作用于红细胞;然而,在4℃时,对神经氨酸酶的需求并不那么显著。如使用可溶性底物(即α1-酸性糖蛋白)进行酶分析所示,在37℃引起血凝的细菌细胞悬液同时含有可溶性细胞外和细胞相关神经氨酸酶活性。细菌介导的血凝仅在存在可溶性神经氨酸酶活性时发生,血凝速率可被2-脱氧-2,3-脱氢-N-乙酰神经氨酸抑制,2-脱氧-2,3-脱氢-N-乙酰神经氨酸是黏性放线菌T14V纯化可溶性神经氨酸酶的竞争性抑制剂。仅含有细胞相关神经氨酸酶活性的细菌悬液无法引发血凝,但当与经神经氨酸酶处理的红细胞混合时,它们会立即引起血凝。所有血凝反应在0.02M乳糖存在下是可逆的,并且通过加热(85℃ 30分钟)放线菌细胞而非红细胞可消除血凝反应。提出的血凝机制涉及两个连续步骤:(i)神经氨酸酶的作用以暴露红细胞上含半乳糖的受体;(ii)这些受体通过细菌表面许多低亲和力凝集素位点的多价结合。